Cristian Massacesi

Insider

First SEC filing: Aug. 5, 2025 · Latest: Aug. 5, 2025

On this page

Insider at

0 buys (P) 0 sells (S) Net: $0 + 4 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
Aug. 1, 2026	BMY	M	51,172	—	—	153,519 Direct	-25.00%	Disposed	(price as of 2026-08-21)
Aug. 1, 2026	BMY	F	26,175	$65.31	$1,709,489	24,997 Direct	-51.15%	Disposed	1.1% (price as of 2026-08-21)
Aug. 1, 2026	BMY	M	51,172	—	—	51,172 Direct	—	Acquired	(price as of 2026-08-21)
Aug. 1, 2025	BMY	A	204,691	—	—	204,691 Direct	—	Acquired	(price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
Aug. 1, 2026	BMY	Restricted Stock Units	Common Stock, $0.10 par value (51,172)	—	Aug. 1, 2029	51,172	Disposed
Aug. 1, 2025	BMY	Restricted Stock Units	Common Stock, $0.10 par value (204,691)	—	Aug. 1, 2029	204,691	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Matched by name from proxy statements (DEF 14A) — verify against the filing.

M.D. EVP, Chief Medical Officer, Head of Development

Fiscal year	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension change	Other	Total
2025	$388,462	$1,125,000	—	—	$660,876	$0	$44,618	$10,072,950

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.